DM Locus in Myotonic Dystrophy
DM Locus in Myotonic Dystrophy
批准号:
6447003
负责人:
RICHARD P. JUNGHANS
金额:
$8.5万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-28 至 2003-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Myotonic dystrophy (DM) is caused by an
expanded trinucleotide repeat that is present in the 3' untranslated region of
the mRNA of DM protein myotonin kinase (DMPK). After many investigations, it
appears that the DM syndrome is a result of diverse mechanisms influencing
different genes: (i) effects of the repeat on the net expression of protein of
DMPK, (ii) effects of the trinucleotide-repeat-containing mRNA itself on cell
	or nuclear functions, and (iii) effects of the repeat on the chromosomal
structure in this region. The research proposal addresses a further potential
mechanism: long-range effects of the DM disease locus on a distant gene,
specifically FCGRT. The'FCGRT gene encodes the heavy chain of the FcRB, the IgG
A protection receptoralpha expressed in vascular endothelial cells that rescues
endocytosed IgG antibody from catabolism. The protection mechanism is depressed
in myotonic dystrophy, compatible with underexpression of the FcRB; receptor.
FCGRT has been mapped to the same chromosomal band (19ql3.3) as the DM locus,
but it is 4 megabases distant. The long-range effects may be confined to the
FCGRT on the same chromosome (cis) or may be experienced by FCGRT on both
chromosomes (trans) in affected individuals. The degree of loss of IgG
protection is compatible with half as much expression of FCGRT, that would be
compatible with a monoallelic suppression. The presence of the DM and FCGRT
genes in the same chromosomal band suggests that their co-localization may be
more than coincidental (p=0.003), i.e., that there is a cis-mechanism by which
DM suppresses the FCGRT gene. If the mechanism is cis, it implies an unusual,
and 	perhaps novel, type of long-range interaction on the DM chromosome,
such as RNA "painting" in analogy to Xist-induced X chromosome inactivation.
For specific aim , we propose: to demonstrate FCGRT suppression as the
mechanism of IgG hypericatabolism in DM, to establish whether the FCGRT
suppression is by a cis or trans mechanism, to begin to elucidate the molecular
basis for these mechanisms. Understanding the means of FCGRT suppression in DM
may suggest new directions of research by which the multisystem/multigene
phenotype of DM may be explained.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards a new clinical trial Advanced infection proof anti HIV gene modified T ce
-
批准号:8957941
-
项目类别:
-
资助金额:$23.02万
-
财政年份:2013
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
Towards a new clinical trial Advanced infection proof anti HIV gene modified T ce
-
批准号:8683491
-
项目类别:
-
资助金额:$17.0万
-
财政年份:2013
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
Potent Designer T cells for HIV/AIDS Immunotherapy
-
批准号:7459905
-
项目类别:
-
资助金额:$20.97万
-
财政年份:2007
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
Potent Designer T cells for HIV/AIDS Immunotherapy
-
批准号:7339005
-
项目类别:
-
资助金额:$25.65万
-
财政年份:2007
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
ANTI-CEA DESIGNER T CELLS IN GASTRIC CANCER, PHASE I TR*
-
批准号:7616713
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2006
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
ANTI-CEA DESIGNER T CELLS IN GASTRIC CANCER, PHASE I TR*
-
批准号:7386794
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2006
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
ANTI-CEA DESIGNER T CELLS IN GASTRIC CANCER, PHASE I TR*
-
批准号:7736620
-
项目类别:
-
资助金额:$3.75万
-
财政年份:2006
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
ANTI-CEA DESIGNER T CELLS IN GASTRIC CANCER, PHASE I TR*
-
批准号:7060549
-
项目类别:
-
资助金额:$28.0万
-
财政年份:2006
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
Designer T Cell Therapy for PML
-
批准号:6801701
-
项目类别:
-
资助金额:$35.9万
-
财政年份:2004
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
Designer T Cell Therapy for PML
-
批准号:7057815
-
项目类别:
-
资助金额:$35.06万
-
财政年份:2004
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
Designer T Cell Therapy for PML
-
批准号:6890927
-
项目类别:
-
资助金额:$35.9万
-
财政年份:2004
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
Infulence of DM Locus on a Distant Gene (FCGRT) in Myot*
-
批准号:6533058
-
项目类别:
-
资助金额:$8.5万
-
财政年份:2001
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
NEO ANTIGEN AND IMMUNOBIOLOGY OF MEDULLARY BREAST CANCER
-
批准号:6378071
-
项目类别:
-
资助金额:$13.05万
-
财政年份:2000
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
NEO ANTIGEN AND IMMUNOBIOLOGY OF MEDULLARY BREAST CANCER
-
批准号:6189742
-
项目类别:
-
资助金额:$13.05万
-
财政年份:2000
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
ANTICEA IGTCR MODIFIED T CELLS FOR CANCER THERAPY
-
批准号:6326480
-
项目类别:
-
资助金额:$0.44万
-
财政年份:1998
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
ANTICEA IGTCR MODIFIED T CELLS FOR CANCER THERAPY
-
批准号:2616056
-
项目类别:
-
资助金额:$32.42万
-
财政年份:1998
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
T CELLS MODIFIED W/ CHIMERIC ANTICEA IGTCR IN ADENOCARCINOMA
-
批准号:6265433
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
ANTICEA IGTCR MODIFIED T CELLS FOR CANCER THERAPY
-
批准号:6173651
-
项目类别:
-
资助金额:$34.06万
-
财政年份:1998
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
ANTICEA IGTCR MODIFIED T CELLS FOR CANCER THERAPY
-
批准号:6128093
-
项目类别:
-
资助金额:$0.51万
-
财政年份:1998
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
ANTICEA IGTCR MODIFIED T CELLS FOR CANCER THERAPY
-
批准号:2896481
-
项目类别:
-
资助金额:$36.88万
-
财政年份:1998
-
负责人:RICHARD P. JUNGHANS
-
依托单位:
海外基金